Three new studies, two in The Lancet and one in Lancet Oncology, say that people who take aspirin every day may have a lower risk of cancer, reports The New York Times' Roni Caryn Rabin. The studies also showed that aspirin may prevent metastasis when taken by cancer patients. Cancer Minute has more on the Lancet Oncology study here.
The Magic Pill?
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.